Firocoxib Study Leads to Equine Canada Rule Change
By Jessica Semper
Results from a University of Saskatchewan Western College of Veterinary Medicine (WCVM) study have led to a nation-wide change in Equine Canada-sanctioned competition rules regulating the use of the drug firocoxib in performance horses.
The national equine sport organization’s rule change regarding firocoxib’s use came into effect on Jan. 1.
Firocoxib is a non-steroidal anti-inflammatory drug (NSAID) that’s used to treat musculoskeletal inflammation and pain in horses
Create a free account with TheHorse.com to view this content.
TheHorse.com is home to thousands of free articles about horse health care. In order to access some of our exclusive free content, you must be signed into TheHorse.com.
Start your free account today!
Already have an account?
and continue reading.
Related Articles
Stay on top of the most recent Horse Health news with